Mark Robson, Timothy A. Yap, Gaorav P. Gupta, Raquel Andres, Eva Maria Carrasco Carrascal, Bryony Harrop, Desiree Headley, Helen Millward, Samantha Skelton, Colette Lisa Baxter, Nicola Little, Paul A. Dickinson, Mary Stuart, Graeme Smith, Ian C. Smith. "Phase IIa, open-label, multi-center study of the DNA polymerase theta inhibitor ART6043 administered orally in combination with olaparib to patients with HER2-negative breast cancer with a germline BRCA1/2 mutation (randomized expansion of study NCT05898399).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps1165